EDSA:Edesa Biotech Inc - Stock Price Quote and Dividend Data
EDSA STOCK PRICE LATEST CLOSE
$2.23
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Edesa Biotech Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Edesa Biotech Inc Stock Price Information
52-Week Low/High Stock Price$1.55 - $5.59
Percent Held by Institutions1.68%
Revenue$0
Net Income$-7,726,100
Cash Flow$-6,518,083
EPS-0.48%
Market Cap$15,440,230
PE Ratio0
PE Ratio to Industry123%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-50.97%
Total Return Last 3 Years-88.18%
Total Return Last 5 Years-86.17%
Latest Trade DateApr. 09, 2025
Edesa Biotech Inc Annual Stock Dividends
No Data available for Payment History.
Edesa Biotech Inc Dividend Payment History
| No dividends retrieved for EDSA |
Edesa Biotech Inc Other Dividend Details
Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company developing various ways to treat inflammatory and immune-related diseases. Co.'s advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. It is evaluating EB05 in a Phase III study as a potential treatment for acute respiratory distress syndrome (ARDS), a life-threatening form of respiratory failure. In addition, the Co. is developing an sPLA2 inhibitor, EB01 (daniluromer), as a topical treatment for chronic allergic contact dermatitis (ACD), a common occupational skin condition.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Feb. 15, 2025EDSA STOCK PRICE DECREASE: Edesa Biotech Inc on 02-15-2025 decreased stock price > 10% from $3.25 to $2.69
Feb. 14, 2025EDSA STOCK PRICE INCREASE: Edesa Biotech Inc on 02-14-2025 increased stock price > 10% from $1.86 to $3.25
Jan. 25, 2025EDSA STOCK PRICE INCREASE: Edesa Biotech Inc on 01-25-2025 increased stock price > 10% from $1.79 to $2.23
Jan. 16, 2025EDSA STOCK PRICE INCREASE: Edesa Biotech Inc on 01-16-2025 increased stock price > 10% from $1.59 to $1.75
Jan. 03, 2025EDSA STOCK PRICE INCREASE: Edesa Biotech Inc on 01-03-2025 increased stock price > 10% from $1.68 to $1.91
Dec. 07, 2024EDSA STOCK PRICE DECREASE: Edesa Biotech Inc on 12-07-2024 decreased stock price > 10% from $2.11 to $1.77
Dec. 06, 2024EDSA STOCK PRICE DECREASE: Edesa Biotech Inc on 12-06-2024 decreased stock price > 10% from $2.43 to $2.11
Nov. 05, 2024EDSA STOCK PRICE DECREASE: Edesa Biotech Inc on 11-05-2024 decreased stock price > 10% from $3.30 to $2.57
Oct. 25, 2024EDSA STOCK PRICE DECREASE: Edesa Biotech Inc on 10-25-2024 decreased stock price > 10% from $3.68 to $3.31
Jul. 17, 2024EDSA STOCK PRICE INCREASE: Edesa Biotech Inc on 07-17-2024 increased stock price > 10% from $4.24 to $4.77
Apr. 10, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-10-2025 decreased stock price > 10% from $0.65 to $0.52
Apr. 10, 2025SXTP STOCK PRICE DECREASE: 60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $2.87 to $2.50
Apr. 10, 2025BMYMP STOCK PRICE DECREASE: $2 Cv. Pfd./Bristol Myers Squibb Co. on 04-10-2025 decreased stock price > 10% from $1,003.20 to $901.50
Apr. 10, 2025PBMWW STOCK PRICE DECREASE: Wt Exp/Psyence Biomedical Ltd on 04-10-2025 decreased stock price > 10% from $0.03 to $0.02
Apr. 10, 2025UPC STOCK PRICE DECREASE: Ord Shs (New)/Universe Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $3.95 to $3.28
Apr. 10, 2025SXTPW STOCK PRICE DECREASE: Wt Exp/60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.04
Apr. 10, 2025RGBP STOCK PRICE DECREASE: Regen BioPharma Inc on 04-10-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 10, 2025DRRX STOCK PRICE DECREASE: Durect Corp on 04-10-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 10, 2025IXHL STOCK PRICE DECREASE: Incannex Healthcare Inc on 04-10-2025 decreased stock price > 10% from $0.84 to $0.68
Apr. 10, 2025CLABF STOCK PRICE DECREASE: Com No Par/Core One Labs Inc on 04-10-2025 decreased stock price > 10% from $0.09 to $0.04
